Amneal Pharmaceuticals Inc (AMRX) Reports 14% Increase in Q3 2023 Net Revenue

Adjusted EBITDA Grows by 22% Year-Over-Year

Related Keywords

,Company Performance Analysis ,Amneal Pharmaceuticals Inc ,Pharmaceuticals Inc ,Amneal Pharmaceuticals ,Net Revenue ,Diluted Eps ,